🍽️ Coenzyme Q10

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations    |     πŸ“ Dosage Seen

Data Contradictions β€” Limits of Certainity

Impacted of Coenzyme Q10 On Probiotics

Rank Probiotic Impact

Bacteria Impacted by Coenzyme Q10

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Bacteroidota phylum Decreases 📓 Source Study Over 70%ile, prone to being fat
Pseudomonadota phylum Decreases 📓 Source Study
Spirochaetota phylum Decreases 📓 Source Study
Actinomycetota phylum Increases 📓 Source Study
Bacillota phylum Increases 📓 Source Study

Impact of Coenzyme Q10 on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 1.7 0.6 1.83
ADHD 1.1 0.6 0.83
Allergic Rhinitis (Hay Fever) 0.6 0.5 0.2
Allergies 0.5 0.6 -0.2
Allergy to milk products 0.5 0.5 0
Alopecia (Hair Loss) 0.5 0.6 -0.2
Alzheimer's disease 2.2 1.1 1
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.1 1.1
Ankylosing spondylitis 1 0.6 0.67
Anorexia Nervosa 0.6 -0.6
Asthma 1.1 1.1
Atherosclerosis 1.1 -1.1
Autism 2.2 1.6 0.38
Barrett esophagus cancer 0.5 0.5
Bipolar Disorder 1.1 1.2 -0.09
Celiac Disease 1.1 0.5 1.2
Chronic Fatigue Syndrome 1.1 1.1
Chronic Kidney Disease 1.6 1.6
Chronic Urticaria (Hives) 0.5 1.1 -1.2
Colorectal Cancer 0.5 0.5
Constipation 0.5 0.5
COVID-19 2.2 2.2 0
Crohn's Disease 1.1 1.1 0
cystic fibrosis 0.6 -0.6
Depression 1.7 2.7 -0.59
Dermatomyositis 1.6 1.6
Eczema 0.5 0.5
Endometriosis 0.5 1.2 -1.4
Eosinophilic Esophagitis 1.6 1.6
Epilepsy 1.7 1.7 0
Functional constipation / chronic idiopathic constipation 1.6 1.1 0.45
gallstone disease (gsd) 0.5 0.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.5 0.6 1.5
Generalized anxiety disorder 0.5 0.5
Gout 0.5 0.5
Graves' disease 1.1 0.6 0.83
Hidradenitis Suppurativa 0.6 0.6
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.5 0.5
Hyperlipidemia (High Blood Fats) 0.5 1.1 -1.2
hypertension (High Blood Pressure 1.1 -1.1
Hypothyroidism 0.6 0.6
Inflammatory Bowel Disease 1.1 1.7 -0.55
Insomnia 0.6 1.1 -0.83
Irritable Bowel Syndrome 1.7 0.6 1.83
Juvenile idiopathic arthritis 1.1 0.6 0.83
Long COVID 1.6 1.1 0.45
Metabolic Syndrome 1.1 1.7 -0.55
Mood Disorders 2.2 2.7 -0.23
Multiple Sclerosis 1.1 1.1 0
Neuropathy (all types) 0.5 1.6 -2.2
neuropsychiatric disorders (PANDAS, PANS) 1.1 1.1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 0.6 -0.2
Obesity 1.1 1.2 -0.09
obsessive-compulsive disorder 0.5 0.5
Osteoarthritis 0.6 0.6
Osteoporosis 1.1 1.1
Parkinson's Disease 1.2 1.2
Polycystic ovary syndrome 0.5 0.5
Premenstrual dysphoric disorder 0.5 -0.5
Psoriasis 1.7 -1.7
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.1 0.6 0.83
Rosacea 1.1 1.1 0
Schizophrenia 2.2 1.1 1
Sjögren syndrome 0.6 1.6 -1.67
Sleep Apnea 0.6 0.6 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.6 0.6
Stress / posttraumatic stress disorder 1.2 1.2
Systemic Lupus Erythematosus 1.7 1 0.7
Type 1 Diabetes 0.5 2.2 -3.4
Type 2 Diabetes 1.1 2.2 -1
Ulcerative colitis 1.1 1.7 -0.55

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)